English   español  

Browsing by Author Palumbo, Antonio

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 22  next >
RightsPreviewIssue DateTitleAuthor(s)Type
openAccess4 randomized trials.pdf.jpg2013Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsBringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapyMateos, Maria Victoria; Bringhen, Sara; Richardson, Paul G.; Lahuerta, Juan José; García-Sanz, Ramón; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyMorabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2016Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myelomaDonk, Niels W. C. J. van de; Moreau, Philippe; Plesner, Torben; Palumbo, Antonio; Gay, Francesca; Laubach, Jacob P.; Malavasi, Fabio; Avet-Loiseau, Hervé; Mateos, Maria Victoria; Sonneveld, Pieter; Lokhorst, Henk M.; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2012European perspective on multiple myeloma treatment strategies: Update following recent congressesLudwig, Heinz; Bladé, Joan; Cavo, Michele; Moreau, Philippe; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
openAccessrefractorymultiplemyeloma.pdf.jpg2014Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaDimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg14-Mar-2019High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myelomaThakurta, Anjan; Ortiz, María; Blecua, Pedro; Towfic, Fadi; Corre, Jill; Serbina, Natalya V.; Flynt, Erin; Yu, Zhinuan; Yang, Zhihong; Palumbo, Antonio; Dimopoulos, Meletios A.; Gutiérrez, Norma Carmen; Goldschmidt, Hartmut; Sonneveld, Pieter; Avet-Loiseau, Hervéartículo
closedAccessaccesoRestringido.pdf.jpg2012How to manage neutropenia in multiple myelomaPalumbo, Antonio; Bladé, Joan; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2014Initial treatment of transplant-ineligible patients in multiple myelomaMateos, Maria Victoria; Leleu, Xavier; Palumbo, Antonio; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2009International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationPalumbo, Antonio; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessIxazomib_Dimopoulos_PV_Art2020.pdf.jpg2020Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation: The phase III TOURMALINE-MM4 trialDimopoulos, Meletios A.; Špička, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria Victoria; Morgan, Gareth J.; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagarartículo
closedAccessaccesoRestringido.pdf.jpg2014New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)Ocio, Enrique M. CSIC ORCID ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, S.; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2011Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: Consensus statementPalumbo, Antonio; Delforge, Michel; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2019Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialDimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja C.; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Ki Min, Chang; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth J.; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B.; Gupta, Neeraj; Labotka, Richard; Rajkumar, S. Vincentartículo
openAccesspersistentoverall.pdf.jpg2013Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myelomaSan Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2011Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)Palumbo, Antonio; Bladé, Joan; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessPlasma cell leukemia.pdf.jpg2013Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupFernández de Larrea, Carlos; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Dimopoulos, Meletios A.; Chanan-Khan, Asher A.; Moreau, Philippe; Merlini, Giampolo; Lahuerta, Juan José; Bladé, Joan; Orlowski, R. Z.artículo
closedAccessaccesoRestringido.pdf.jpg2013Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trialSan Miguel, Jesús F. CSIC ORCID; Martínez-López, Joaquín; Palumbo, Antonio; Dimopoulos, Meletios A.artículo
closedAccessaccesoRestringido.pdf.jpg2011Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients?Palumbo, Antonio; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2012Proteasome inhibitors in multiple myeloma: 10 years laterMoreau, Philippe; Richardson, Paul G.; Cavo, Michele; Orlowski, R. Z.; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Harousseau, Jean-Lucartículo